Company intelligence
Morphic Medical
Medical Device
Boston, US
58 employees
Founded 2003
3 public signals
About Morphic Medical
Morphic Medical (formerly GI Dynamics Inc.) is the developer of RESET® (fka EndoBarrier), an endoscopically delivered device therapy that offers a non-surgical, alternative treatment for the treatment of type 2 diabetes and obesity. RESET is approved for sale in the EU and UK and limited to Investigational Use in the U.S. Founded in 2003, Morphic Medical is headquartered in Boston, Massachusetts.
Verified activity
Signals from Morphic Medical
3 published signals
Presence & Recognition
Morphic Medical is attending the SICOB National Congress in Pisa for the 2026 event on Sept 17-19.
Reported by Morphic Medical
Products & Services
Morphic Medical launched RESET Therapy, an endoscopic solution designed to deliver immediate weight reduction and metabolic improvement for patients with Type 2 Diabetes and obesity, available in Europe and the UK and limited to Investigational Use in the U.S.
Reported by Morphic Medical
People
Morphic Medical welcomed Lina Ginnetti as Vice President of Clinical Affairs.
Reported by Morphic Medical